Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease

This study aimed to explore the N6-methyladenosine (m6A) modification genes involved in the pathogenesis of Parkinson’s disease (PD) through data analysis of the two data sets GSE120306 and GSE22491 in the GEO database and further explore its influence on cell phenotype in PD. We analyzed the differ...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Quan, Jia Li, Li Liu, Qinghui Zhang, Yidan Qin, Xiaochen Pei, Jiajun Chen
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2021/9919129
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RNA N6-Methyladenosine Modifications and the Immune Response
by: Ya-Nan Wang, et al.
Published: (2020-01-01)

New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy
by: Mengran Li, et al.
Published: (2025-01-01)

Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC
by: Yulin Zhang, et al.
Published: (2025-02-01)

Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis
by: Lei Wan, et al.
Published: (2022-01-01)

N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis
by: Haisheng Zhang, et al.
Published: (2025-01-01)

3-Acetyldeoxynivalenol induces pyroptosis in leydig cells via METTL3-mediated N6-methyladenosine modification of NLRP3
by: Yangyun Wang, et al.
Published: (2025-01-01)

N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate
by: Pengfei Ji, et al.
Published: (2018-01-01)

Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N6-Methyladenosine RNA Methylation Regulators
by: Yan Zhang, et al.
Published: (2021-01-01)

The role of N6-methyladenosine (m6A) mediated LncRNA DDIT3 upregulation in chondrocyte ferroptosis in ankylosing spondylitis
by: Huiping Wang, et al.
Published: (2025-02-01)

Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction
by: Xianpei Wang, et al.
Published: (2022-01-01)

Writers, readers, and erasers of N6-Methyladenosine (m6A) methylomes in oilseed rape: identification, molecular evolution, and expression profiling
by: Chaofan Shan, et al.
Published: (2025-02-01)

Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
by: Xian Lin, et al.
Published: (2023-04-01)

RNA N6‐Methyladenosine‐Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN‐γ Signaling in Gastric Cancer
by: Dongjun Jang, et al.
Published: (2025-01-01)

Biosynthesis inhibition of miR-142-5p in a N 6-methyladenosine-dependent manner induces neuropathic pain through CDK5/TRPV1 signaling
by: Jinshi Li, et al.
Published: (2025-01-01)

FTO attenuates TNF-α-induced damage of proximal tubular epithelial cells in acute pancreatitis-induced acute kidney injury via targeting AQP3 in an N6-methyladenosine-dependent manner
by: Xinghui Li, et al.
Published: (2024-12-01)

The N1‐methyladenosine methyltransferase TRMT61A promotes bladder cancer progression and is targetable by small molecule compounds
by: Jianjian Yin, et al.
Published: (2025-01-01)

Physical Activity across Frailty Phenotypes in Females with Parkinson’s Disease
by: Kaitlyn P. Roland, et al.
Published: (2012-01-01)

Protocol for measuring the auxin-induced changes of m6A modification
by: Bin Li, et al.
Published: (2025-03-01)

RNA N4‐acetylcytidine modification and its role in health and diseases
by: Qiang Wang, et al.
Published: (2025-01-01)

Potential Therapeutic Drugs for Parkinson’s Disease Based on Data Mining and Bioinformatics Analysis
by: Chuan Xu, et al.
Published: (2018-01-01)

Gene Therapy for Parkinson's Disease
by: Rachel Denyer, et al.
Published: (2012-01-01)

METTL3-Mediated m6A Modification Regulates the Osteogenic Differentiation through LncRNA CUTALP in Periodontal Mesenchymal Stem Cells of Periodontitis Patients
by: Xin Chen, et al.
Published: (2024-01-01)

Compensatory synaptotagmin-11 expression conceals parkinson’s disease-like phenotypes in parkin knockout mice
by: Nan Dong, et al.
Published: (2025-02-01)

Pain in Parkinson's Disease Associated with COMT Gene Polymorphisms
by: Wanjun Li, et al.
Published: (2014-01-01)

N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
by: Qihui Wu, et al.
Published: (2025-01-01)

M6A Modification and Transcription Analysis of LncRNA in Cerebral Ischemia/Reperfusion Injury
by: Jierong Mo, et al.
Published: (2024-01-01)

Clinically probable RBD is an early predictor of malignant non-motor Parkinson’s disease phenotypes
by: Alfonso Enrique Martinez-Nunez, et al.
Published: (2025-01-01)

CLN6‐related continuum phenotype caused by aberrant splicing
by: Federica Invernizzi, et al.
Published: (2025-02-01)

Systematic ocular phenotyping of 8,707 knockout mouse lines identifies genes associated with abnormal corneal phenotypes
by: Peter Vo, et al.
Published: (2025-01-01)

Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson’s Disease
by: Ya-Chao He, et al.
Published: (2017-01-01)

Two Novel Variants in the ATRX Gene Associated with Variable Phenotypes
by: D. Hettiarachchi, et al.
Published: (2019-01-01)

n-GaAs Band-Edge Repositioning by Modification with Metalloporphyrin/Polysiloxane Matrices
by: Hikmat S. Hilal, et al.
Published: (2003-01-01)

ANALYSIS OF THE INTERACTIONS OF NEURONAL APOPTOSIS GENES IN THE ASSOCIATIVE GENE NETWORK OF PARKINSON’S DISEASE
by: M. A. Yankina, et al.
Published: (2018-03-01)

Application of PEI-Modified Magnetic Nanoparticles as Gene Transfer Vector for the Genetic Modification of Animals
by: Jinhui Cui, et al.
Published: (2012-01-01)

Bisecting GlcNAc modification of vesicular GAS6 regulates CAFs activation and breast cancer metastasis
by: Jing Li, et al.
Published: (2025-01-01)

Variants in the 3′ End of SLC6A3 in Northwest Han Population with Parkinson’s
by: Peiye Chang, et al.
Published: (2019-01-01)

The Association between LRRK2 G2385R and Phenotype of Parkinson’s Disease in Asian Population: A Meta-Analysis of Comparative Studies
by: Wei Di, et al.
Published: (2018-01-01)

Improved 11α-hydroxycanrenone production by modification of cytochrome P450 monooxygenase gene in Aspergillus ochraceus
by: Li Qianqian, et al.
Published: (2021-03-01)

Genotype-Phenotype Correlation of G6PD Mutations among Central Thai Children with G6PD Deficiency
by: Boonchai Boonyawat, et al.
Published: (2021-01-01)

The crystal structure of [bis(2,2′-bipyridine-6-carboxylato-κ3N,N,O)magnesium(II)]dihydrate, C22H18N4O6Mg
by: Xi-Shi Tai, et al.
Published: (2023-10-01)